Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

@article{Afzal2007TreatmentWM,
  title={Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome},
  author={Kamran Afzal and Arvind Bagga and Shina Menon and Pankaj Hari and Stanley C. Jordan},
  journal={Pediatric Nephrology},
  year={2007},
  volume={22},
  pages={2059-2065}
}
The management of patients with steroid-dependent nephrotic syndrome (SDNS) refractory to treatment with long-term steroids, levamisole and cyclophosphamide is difficult. We report our experience on long-term treatment with mycophenolate mofetil (MMF) and alternate-day prednisolone in 42 patients with SDNS previously treated with levamisole (n = 35) and/or cyclophosphamide (n = 37). The mean age (range) at onset of nephrotic syndrome was 37 (13–92) months and at treatment with MMF 104.7 (32–187… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences • 2015
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Nephrotic syndrome in children.

Current problems in pediatrics • 1988
View 4 Excerpts
Highly Influenced

Therapeutic monitoring of mycophenolate mofetil.

Clinical journal of the American Society of Nephrology : CJASN • 2007
View 3 Excerpts

Antifibrotic actions of mycophenolic acid.

Clinical transplantation • 2006
View 3 Excerpts

Similar Papers

Loading similar papers…